Capsule Early Warning Scoring System (EWSS)

Early detection can make the difference between life and death.

Patients typically show signs of deterioration 8 to 12 hours before a critical event.¹ Now, you can ensure early signs of deterioration are recognized and your care teams know how to respond. Designed to supplement your EMR’s Early Warning Scoring System (EWSS), our system uses hospital-configured scoring systems and interventions to identify patients at risk and guide care teams right at the bedside. This optional add-on to Capsule Vitals Plus or Chart Xpress* is an ideal tool for non-critical care areas.

Reliable, accurate assessment of patient decline

Registers subtle changes in vital signs captured through Vitals Plus or Chart Xpress
Provides an immediate acuity score based on your custom-configured algorithm
Eliminates manual errors while reducing lag time and guesswork with computerized calculations

Actionable insight reduces complexity and informs timely interventions

Sends score to alarm management systems to activate rapid response teams
Guides care teams step-by-step through the hospital-recommended actions
Displays vital signs history and the previous four scores to place new score in clinical context, regardless of the Vitals Plus or Chart Xpress device

Helps hospitals continuously improve response protocols and outcomes

Transmits results to appropriate downstream systems to support safety initiatives
Automates early recognition of deterioration so it’s more predictably assessed
Can mitigate adverse events and mortality associated with failure to rescue

Not available on Chart Xpress outside the U.S.

Learn more about how Vitals Plus with EWSS can cost-effectively create workflow efficiencies and improve intelligence at the point of care.

Download

Insights & Events

Catch up on the latest from Capsule

March 16, 2022

Patient Monitoring vs. Clinical Surveillance: There are Differences

Blog

Patient monitoring and clinical surveillance, though related, are different. Clinical surveillance uses the results of monitoring to recognize changes in the patient’s clinical status, interpret the potential clinical implications of these changes, and to help clinicians decide if further actions are required.

March 15, 2022

Latest release of Philips Capsule Surveillance receives FDA clearance

Press Release

Capsule Surveillance has received 510(k) market clearance from the U.S. Food & Drug Administration (FDA), paving the way for widespread deployment across healthcare systems in the USA.

Kim WY, Shin YJ, Lee JM, et al. Modified Early Warning Score Changes Prior to Cardiac Arrest in General Wards. PLoS One. 2015;10(6):e0130523. Published 2015 Jun 22. doi:10.1371/journal.pone.0130523.